Study of Pembrolizumab and M032 (NSC 733972)

Clinical trial NCT05084430 · RECRUITING

Trial details

NCT number: NCT05084430
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Anaplastic Astrocytoma Gliosarcoma

Start date: 2022-02-25
Primary completion: 2027-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.